Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis

B-cell chronic lymphocytic leukemia (B-CLL) cells are resistant to apoptosis, and consequently accumulate to the detriment of normal B cells and patient immunity. Because current therapies fail to eradicate these apoptosis-resistant cells, it is essential to identify alternative survival pathways as...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbaci, A, Talbot, H, Saada, S, Gachard, N, Abraham, J, Jaccard, A, Bordessoule, D, Fauchais, A L, Naves, T, Jauberteau, M O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808079/
https://www.ncbi.nlm.nih.gov/pubmed/29059151
http://dx.doi.org/10.1038/onc.2017.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808079/
https://www.ncbi.nlm.nih.gov/pubmed/29059151
http://dx.doi.org/10.1038/onc.2017.365

Ejemplares similares